Skip to main content
. 2020 Jun 29;12(7):1734. doi: 10.3390/cancers12071734
AFP alpha-fetoprotein
ANXA3 Annexin A3
ApoA-1 apolipoprotein A1
ASGPR asialoglycoprotein receptor
CK cytokeratin
CPS1 carbamoyl phosphate synthetase 1
CSCs cancer stem cells
CTCs circulating tumor cells
ctDNA circulating tumor DNA
EMA epithelial membrane antigen
EMT epithelial to mesenchymal transition
EpCAM epithelial cell adhesion molecule
FDA the US Food and Drug Administration
GPC glypican-3; GS: glutamine synthase
HBV hepatitis b virus
HCC hepatocellular carcinoma
Hep Par 1 hepatocyte paraffin-1
IGFBP1 insulin like growth factor binding protein 1
OS overall survival
pERK phosphorylated ERK
PFS progression-free survival
ROC receiver operating characteristic
RT-PCR reverse transcriptase polymerase chain reaction
TACE transcatheter arterial chemoembolization
TNM tumor-node-metastasis
Treg regulatory T cells